AHA 2019: Cardiawave Sees Positive Early Results For Non-Invasive Valve Disease Treatment

 
• By Phil Greenfield

The French start-up claims first-in-man success for heart valve “softening” treatment and plans further trials for an EU launch.

Valvosoft procedure
Valvosoft delivers ultrasound therapy through the chest to break down calcification of valve leaflets. • Source: Cardiawave S.A.

More from Clinical Trials

More from R&D